Troglitazone, a peroxisome proliferator-activated receptor &gamma; ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells

doi:10.3748/wjg.14.2168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2956)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

277

HTML

2517

Figures (1-7)

162

Sum=2956

Apr 14, 2008 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Apr 14, 2008; 14(14): 2168-2173
Published online Apr 14, 2008. doi: 10.3748/wjg.14.2168

Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells

Yan-Ming Zhou, Yin-Hao Wen, Xiao-Yan Kang, Hai-Hua Qian, Jia-Mei Yang, Zheng-Feng Yin

Yan-Ming Zhou, Yin-Hao Wen, Xiao-Yan Kang, Hai-Hua Qian, Jia-Mei Yang, Zheng-Feng Yin, Department of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China

Correspondence to: Zheng-Feng Yin, MD, Department of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China. yinzfk@yahoo.com.cn

Telephone: +86-21-25070859

Fax: +86-21-25070859

Received: September 19, 2007
Revised: December 12, 2007
Published online: April 14, 2008

Core Tip